Category

SUPPLY CHAIN

Category

President Trump has issued an Executive Order (the Order) directing the Department of Justice (DOJ) and Federal Trade Commission (FTC) to launch investigations into the U.S. food sector, focusing on potential price-fixing, other forms of criminal collusion, and non-criminal anticompetitive conduct. The Order creates new Food Supply Chain Security Task Forces within both agencies, empowered to examine whether anticompetitive behavior—particularly by foreign-controlled companies—is driving up the cost of food products. The Attorney General may pursue…

Tariffs and shifting trade dynamics continue to disrupt healthcare and life sciences supply chains. But in addition to affecting operational and commercial outlooks for business, they are also revealing new opportunities for innovators and investors. In the final article of the series, we explore five key questions:

As supply chains shift and vendor arrangements evolve in response to tariffs, life sciences companies must adapt to increasingly intricate and intertwined challenges across operational and commercial needs. Manufacturing relocation, technology adoption, and new vendor partnerships require careful oversight of labor, compliance, human rights, and union matters. Protecting IP and data is vital against brand, legal, and cyber risks. Early IP registration, strong contracts, audits, and compliance help manage regulations and reduce Anti-Money Laundering (AML)…

Amid fluctuating tariffs and complex trade policies, healthcare and life sciences (HLS) companies face mounting operational and legal challenges within their global supply chains. Organizations are taking steps to retool their supply chains in response to threats against stability, but change introduces myriad knock-on implications. In the second article of the series, we explore four key questions for HLS businesses considering new supply chain strategies:

The healthcare and life sciences sector is facing new trade winds and a looming threat of increased tariffs. This places additional pressure on a typical life sciences supply chain timeline. We recently launched a four-part article series on supply chains, aimed at exploring the legal and operational complexities that healthcare and life sciences companies face as they navigate evolving global supply chain challenges. The first article explores the steps companies can take to ensure business continuity in…

Following the US administration’s’ extensive new import tariffs, many companies are grappling with increased costs and supply chain uncertainty. What happens when a deal becomes financially unsustainable due to government-imposed trade restrictions? Companies should consider the force majeure and change management clauses in their contracts, and the doctrines of impossibility, impracticability and frustration of purpose under applicable statutes and the common law, to assess whether they are entitled to relief. This article examines these potential…

Baker McKenzie’s Global Customs Practice invites you to join us for a follow up webinar on “Trump and Tariffs: Section 232 Tariff Announcement, Reciprocal & Retaliatory Tariffs and More”This one-hour webinar will take place Thursday, 20 February 2025 at 10:00 CST / 11:00 EST / 17:00 CET.On February 10th President Trump announced that 25% tariffs will be imposed on all steel and aluminum products imported into the US from all countries, including Canada, Mexico, the EU and UK, which were previously subject…

Baker McKenzie’s Canadian international trade and customs team is publishing a series of articles reviewing 2024 trade and customs compliance developments and looking ahead to 2025’s burgeoning issues. This article focuses on Canadian legislative and enforcement developments in combatting forced and child labour. Before we dive into Canada’s commitments to combatting forced and child labour, here is an overview of the current state of politics in Canada, which includes a discussion of the legislative powers…

Baker McKenzie’s Global Customs Practice invites you to join us for a webinar we’ll be hosting on “Trump and Tariffs: Focus on the US, Canada and Mexico”.This one-hour webinar will take place Wednesday, 5 February 2025 at 10:00 Mexico City / 11:00 EST / 17:00 CET. On February 1st 2025, President Trump signed executive orders imposing the long-anticipated tariffs he has called on for Canada and Mexico including 25% tariffs on non-energy imports from Canada and on all imports from Mexico…

President Trump signed an executive order on February 1, 2025 (“Executive Order“), imposing the long-anticipated tariffs on Canada, Mexico, and China under the International Emergency Economic Powers Act (“U.S. Tariffs“).Canada retaliated swiftly by implementing retaliatory tariffs/countermeasures at a rate of 25% pursuant to sections 53 and 79 of the Customs Tariff by way of an Order in Council (United States Surtax Order (2025) (“Canada Tariffs“). Read the Government of Canada’s press release here. For the past two decades, goods have largely flowed across North…